Oral Cancer in the Baltic States: Key Statistics

Oral Cancer in the Baltic States: Key Statistics

The Baltic states — Latvia, Lithuania, and Estonia — face distinct challenges when it comes to oral cancer detection and treatment. Understanding the regional landscape is essential for improving outcomes.

The Numbers

Across the Baltic region, approximately 1,500 new cases of oral and oropharyngeal cancer are diagnosed annually. Latvia consistently reports some of the highest incidence rates in the European Union, with late-stage diagnosis remaining disproportionately common.

Key statistics for the region:

• Oral cancer incidence in Latvia is approximately 40% higher than the EU average
• More than 60% of cases are diagnosed at stage III or IV
• The five-year survival rate in the Baltic states is approximately 50%, compared to 65% in Scandinavia
• Men are affected roughly three times more frequently than women

Why Late Detection Persists

Several structural factors contribute to delayed diagnosis in the Baltic states:

• **Specialist concentration** — oral medicine specialists are primarily located in capital cities, creating access barriers for rural populations
• **Limited screening programs** — unlike cervical or breast cancer, systematic oral cancer screening is not widely implemented
• **Low public awareness** — many patients do not recognize early warning signs or delay seeking evaluation

Bridging the Gap

Digital platforms like OriScan are designed specifically to address these challenges. By enabling remote case submission and specialist review, geographic barriers are reduced. Patients in Liepāja, Tartu, or Kaunas can access the same specialist expertise as those in Riga — within 48 hours.

Improving early detection rates in the Baltic region requires a combination of public education, accessible screening, and modern digital tools. The technology exists; the challenge is adoption.